Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 360

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen-Induced Arthritis via T Cell Apoptosis

Open access
Rabinovich, Gabriel A., Daly, Gordon, Dreja, Hanna, Tailor, Hitakshi, Riera, Clelia M., Hirabayashi, Jun, Chernajovsky, Yuti · 1999 · The Journal of Experimental Medicine

Abstract

Galectin-1 (GAL-1), a member of a family of conserved β-galactoside–binding proteins, has been shown to induce in vitro apoptosis of activated T cells and immature thymocytes. We assessed the therapeutic effects and mechanisms of action of delivery of GAL-1 in a collagen-induced arthritis model. A single injection of syngeneic DBA/1 fibroblasts engineered to secrete GAL-1 at the day of disease onset was able to abrogate clinical and histopathological manifestations of arthritis. This effect was reproduced by daily administration of recombinant GAL-1. GAL-1 treatment resulted in reduction in anticollagen immunoglobulin (Ig)G levels. The cytokine profile in draining lymph node cells and the anticollagen IgG isotypes in mice sera at the end of the treatment clearly showed inhibition of the proinflammatory response and skewing towards a type 2–polarized immune reaction. Lymph node cells from mice engaged in the gene therapy protocol increased their susceptibility to antigen-induced apoptosis. Moreover, GAL-1–expressing fibroblasts and recombinant GAL-1 revealed a specific dose-dependent inhibitory effect in vitro in antigen-dependent interleukin 2 production to an Aq-restricted, collagen type 2–specific T cell hybridoma clone. Thus, a correlation between the apoptotic properties of GAL-1 in vitro and its immunomodulatory properties in vivo supports its therapeutic potential in the treatment of T helper cell type 1–mediated autoimmune disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.190.3.385

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 13

  1. Van den Brüle, 1995, GAL-1 modulates human melanoma cell adhesion to laminin, Biochem. Biophys. Res. Commun., 209, 760, 10.1006/bbrc.1995.1564 · doi:10.1006/bbrc.1995.1564
  2. Blaser, 1998, Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells, Eur. J. Immunol., 28, 2311, 10.1002/(SICI)1521-4141(199808)28:08<2311::AID-IMMU2311>3.0.CO;2-G · doi:10.1002/(sici)1521-4141(199808)28:08<2311::aid-immu2311>3.0.co;2-g
  3. Levy, 1983, Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits, Eur. J. Immunol., 13, 500, 10.1002/eji.1830130613 · doi:10.1002/eji.1830130613
  4. Rabinovich, 1996, Regulated expression of a 16-kd galectin-like protein in activated rat macrophages, J. Leukocyte Biol., 59, 363, 10.1002/jlb.59.3.363 · doi:10.1002/jlb.59.3.363
  5. Allen, 1990, Role of galaptin in ovarian carcinoma adhesion to extracellular matrix in vitro, J. Cell. Biochem., 43, 43, 10.1002/jcb.240430105 · doi:10.1002/jcb.240430105
  6. Chernajovsky, 1995, Gene therapy in rheumatoid arthritis via cytokine regulationfuture perspectives, Br. Med. Bull., 51, 503, 10.1093/oxfordjournals.bmb.a072976 · doi:10.1093/oxfordjournals.bmb.a072976
  7. Rabinovich, 1997, Specific inhibition of lymphocyte proliferation and induction of apoptosis by CLL-I, a β-galactoside-binding lectin, J. Biochem., 122, 365, 10.1093/oxfordjournals.jbchem.a021762 · doi:10.1093/oxfordjournals.jbchem.a021762
  8. Cyster, 1994, Antigen determinants encoded by alternatively spliced exons of CD45 are determined by the polypeptide but influenced by glycosylation, Int. Immunol., 6, 1875, 10.1093/intimm/6.12.1875 · doi:10.1093/intimm/6.12.1875
  9. Jorgensen, 1998, Gene therapy in osteoarticular diseaseswhere are we?, Immunol. Today, 19, 387, 10.1016/S0167-5699(98)01296-1 · doi:10.1016/s0167-5699(98)01296-1
  10. Cortegano, 1998, Galectin-3 down-regulates IL-5 gene expression on different cell types, J. Immunol., 161, 385, 10.4049/jimmunol.161.1.385 · doi:10.4049/jimmunol.161.1.385
  11. Evans, 1996, Pathways to gene therapy in rheumatoid arthritis, Curr. Opin. Rheumatol., 8, 230, 10.1097/00002281-199605000-00011 · doi:10.1097/00002281-199605000-00011
  12. Chernajovsky, 1995, Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor, Gene Therapy., 2, 731
  13. Burt, 1997, Bone marrow transplantation for multiple sclerosisreturning to Pandora's box, Immunol. Today., 12, 559, 10.1016/S0167-5699(97)01168-7 · doi:10.1016/s0167-5699(97)01168-7

Cited by

See all 360

Metadata

Authors
Rabinovich, G. A., Daly, G., Dreja, H., Tailor, H., Riera, C. M., Hirabayashi, J., & Chernajovsky, Y.
Venue
The Journal of Experimental Medicine
Published
1999-08-02
Volume
190
Issue
3
Pages
385-398
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2043763521
Cited by
360
References
44
FWCI
5.66
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.